Atlas Trials

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Clinical trial NCT01275664 · TERMINATED

Trial details

NCT number
NCT01275664
Sponsor
Gynecologic Oncology Group
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Nausea and VomitingOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous CystadenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous CystadenocarcinomaStage II Ovarian CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIB Fallopian Tube CancerStage IIB Ovarian Cancer
Start date
2011-06-01
Primary completion
2014-05-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.